These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Glucocorticoids for dermatologic disorders]. Kitajima Y Nihon Rinsho; 1994 Mar; 52(3):754-9. PubMed ID: 8164378 [TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. De Nijs RN Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacology of glucocorticoids and ENT pathology]. Devillier P Presse Med; 2001 Dec 22-29; 30(39-40 Pt 2):59-69. PubMed ID: 11819915 [TBL] [Abstract][Full Text] [Related]
8. [New therapeutic concepts for vasculitis and collagenosis]. Metzler C; Hellmich B; Gause A Internist (Berl); 2005 Dec; 46(12):1347-53. PubMed ID: 16267676 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced osteoporosis: unawareness or negligence in India? Gera C; Vij AS Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351 [TBL] [Abstract][Full Text] [Related]
10. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort]. Rotenberger J; Köbberling J Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721 [No Abstract] [Full Text] [Related]
12. [Glucocorticoid therapy in the course of time]. Kaiser H; Burmester GR; Buttgereit F Z Rheumatol; 2005 Apr; 64(3):147-8. PubMed ID: 15868330 [No Abstract] [Full Text] [Related]
13. Prevention and treatment of glucocorticoid-induced osteoporosis in daily dermatologic practice. Vermaat H; Kirtschig G Int J Dermatol; 2008 Jul; 47(7):737-42. PubMed ID: 18613886 [TBL] [Abstract][Full Text] [Related]
15. An overview of the adverse reactions to adrenal corticosteroids. Frauman AG Adverse Drug React Toxicol Rev; 1996 Nov; 15(4):203-6. PubMed ID: 9113247 [TBL] [Abstract][Full Text] [Related]
16. [Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment]. Tanaka H Clin Calcium; 2009 Apr; 19(4):569-73. PubMed ID: 19329838 [TBL] [Abstract][Full Text] [Related]
17. Systemic glucocorticoids: important issues and practical guidelines for the dermatologist. Dodiuk-Gad RP; Ish-Shalom S; Shear NH Int J Dermatol; 2015 Jun; 54(6):723-9. PubMed ID: 25683616 [TBL] [Abstract][Full Text] [Related]
18. [Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis]. Suzuki Y Clin Calcium; 2014 Mar; 24(3):417-24. PubMed ID: 24576939 [TBL] [Abstract][Full Text] [Related]
19. [The usefulness of the quantitative ultrasound to diagnose glucocorticoids induced osteoporosis]. Ponteggia M; Ponteggia F; Di Cato L; Puxeddu A; Coaccioli S Minerva Med; 2002 Dec; 93(6):485-90. PubMed ID: 12515972 [TBL] [Abstract][Full Text] [Related]